Subgroup | Number of studies | Sample size | Pooled mean score (95% CI) | Model | Pa | Heterogeneity | ||
---|---|---|---|---|---|---|---|---|
I2 (%) | Q | Pb | ||||||
Sample size | Â | Â | Â | Â | 0.01* | Â | Â | Â |
<300 | 13 | 2988 | 2.70(2.55,2.85) | Random |  | 97.8 | 553.45 | < 0.001 |
300–500 | 15 | 6186 | 2.58(2.41,2.74) | Random |  | 98.9 | 1304.06 | < 0.001 |
>500 | 6 | 4271 | 2.95(2.77,3.14) | Random |  | 98.9 | 518.29 | < 0.001 |
Publication year | Â | Â | Â | Â | 0.30 | Â | Â | Â |
<2019 | 12 | 5453 | 2.82(2.60,3.03) | Random |  | 99.4 | 1672.66 | < 0.001 |
2019–2021 | 13 | 5517 | 2.68(2.54,2.81) | Random |  | 97.8 | 525.88 | < 0.001 |
2022–2023 | 9 | 2475 | 2.59(2.38,2.79) | Random |  | 98.1 | 476.37 | < 0.001 |
Country |  |  |  |  | < 0.01* |  |  |  |
China | 29 | 11,739 | 2.68(2.56,2.80) | Random |  | 98.9 | 2816.81 | < 0.001 |
Turkey | 4 | 1405 | 2.93(2.75,3.11) | Random |  | 95.2 | 72.22 | < 0.001 |
South Korea | 1 | 301 | 2.42(2.36,2.48) | Random | Â | - | - | - |
Scale | Â | Â | Â | Â | 0.06 | Â | Â | Â |
ESB | 12 | 5222 | 2.83(2.68,2.99) | Random |  | 96.7 | 694.99 | < 0.001 |
NOSB | 17 | 6517 | 2.57(2.42,2.72) | Random |  | 96.8 | 1654.37 | < 0.001 |
OSS | 4 | 1537 | 2.84(2.53,3.15) | Random |  | 96.9 | 315.18 | < 0.001 |
OSBS | 1 | 169 | 2.77(2.63,2.91) | Random | Â | - | - | - |
Department |  |  |  |  | < 0.01* |  |  |  |
multi department | 22 | 5849 | 2.76(2.64,2.89) | Random |  | 98.9 | 1965.95 | < 0.001 |
pediatric | 2 | 524 | 2.26(1.69,2.84) | Random |  | 98.7 | 78.25 | < 0.001 |
operating | 3 | 1035 | 2.70(2.37,3.02) | Random |  | 97.8 | 73.86 | < 0.001 |
tumor | 2 | 682 | 2.43(2.39,2.48) | Fixed | Â | 0 | 0.63 | 0.430 |
others | 5 | 1538 | 2.68(2.37,2.99) | Random |  | 98.8 | 357.49 | < 0.001 |